Agenus Inc. Profile Avatar - Palmy Investing

Agenus Inc.

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human a…

Biotechnology
US, Lexington [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Agenus Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Agenus Inc. can't present revenue by segment

End of AGEN's Analysis
CIK: 1098972 CUSIP: 00847G705 ISIN: US00847G7051 LEI: - UEI: -
Secondary Listings
AGEN has no secondary listings inside our databases.